Dilruba Ahmed, Ph.D.

Dilruba Ahmed, Ph.D. has a diverse work experience spanning over several years. Dilruba is currently working as the Director of QA & RA at Elypta since February 2023. Prior to this, they served as the QA/QC Manager at Prostatype Genomics AB from August 2019 to February 2023, and previously as the QC Manager/ Application Specialist from October 2019 to August 2021. Dilruba also worked as a Laboratory Engineer at Clinical Microbiology at Karolinska Universitetslaboratoriet from January 2019 to July 2019.

Dilruba'sresearch experience includes being a Research Assistant at Karolinska Institutet from October 2017 to December 2018. Dilruba also worked as a Researcher/Ph.D. Candidate at Karolinska Institutet from October 2012 to April 2017, where their focus was on investigating the role of bio-active sphingolipids and their metabolizing enzymes in cancer, specifically in Hepatocellular carcinoma and Bladder cancer. Dilruba conducted studies to examine the potential of combination treatments involving sphingolipid analogues and existing anticancer agents. Additionally, they served as a Project Assistant at Karolinska Institutet from November 2011 to September 2012.

In the early stages of their career, Dilruba worked as a Senior Product Marketing Officer at Rangs Pharmaceuticals Ltd. from March 2008 to August 2010. Dilruba also gained practical experience through an internship at Renata Limited, a pharmaceutical company, as part of their Bachelor of Pharmacy education program, where they learned about pharmaceutical manufacturing, quality control and assurance, procurement, and marketing processes in May 2006.

Overall, Dilruba Ahmed, Ph.D. has a well-rounded background in quality assurance, research, and project management, with specific expertise in the field of cancer research and pharmaceuticals.

Dilruba Ahmed, Ph.D. has an extensive education history. Dilruba started their academic journey by completing a Bachelor's Degree in Pharmacy from Jahangirnagar University between 2001 and 2004. Subsequently, they pursued a Master's Degree in Pharmaceutical Sciences from the same university, which they obtained from 2004 to 2005. In 2010, they enrolled at Södertörn University and earned a Master's Degree in Infectious Disease Control, graduating in 2012. Ahmed then went on to earn a Doctor of Philosophy (Ph.D.) in Medical Science from Karolinska Institutet between 2012 and 2016.